New migraine combo drug passes early safety check
NCT ID NCT06578585
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 28 times
Summary
This early-stage study looked at whether a new drug called Lu AG09222 is safe to take together with the migraine medication ubrogepant. 43 adults with migraine received ubrogepant pills plus an injection of either Lu AG09222 or a placebo. The main goal was to track any side effects and measure how the drugs interact in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Neuroscience Solutions
Orlando, Florida, 32801, United States
-
Elevate Clinical Research
Seabrook, Texas, 77586, United States
-
Future Search Trials
Austin, Texas, 78731, United States
-
NeuroTrials Research
Atlanta, Georgia, 30328, United States
Conditions
Explore the condition pages connected to this study.